Endocrinology 1
Endocrinology 2
Endocrinology 3
Dermatology 1
Dermatology 2
100

Thyroid cancer associated with MEN types 2A and 2B

Medullary

100

First lab test for thyroid nodule

TSH level

100

Electrolyte abnormality following thyroid surgery

Hypocalcemia (from parathyroid injury)

100

Diagnosis of annular scaly patch with central clearing

Tinea infection

100

Topical treatment for impetigo

Mupirocin or retapamulin

200

Treatment of nonthyroidal illness syndrome

Observation

200

Most common cause of non–PTH-mediated hypercalcemia

Malignancy

200

T1DM antibody testing in new diagnosis

Glutamic acid decarboxylase (GAD)

200

Pigmented macule with a surrounding hypopigmentation

Halo nevus

200

Cause of linearly arranged pruritic papules found in the morning

Bed bug bites

300

Treatment of men with biochemically proven hypogonadism

Testosterone therapy

300

Main two options for blood glucose monitoring (BGM)

Fingerstick BGM and continuous glucose monitoring (CGM)

300

Drugs for diabetic peripheral neuropathy

Gabapentinoids, SNRIs, tricyclic antidepressants, sodium channel blockers

300

Pearly or translucent nodule or papule with arborizing telangiectasias, often with central depression with rolled waxy border

Nodular basal cell carcinoma

300

Three-color targetoid lesions on face and acral sites

Erythema multiforme

400

TSH level indication for subclinical hypothyroidism treatment

>10 µU/mL

400

Diagnosis of osteoporosis in postmenopausal women and men >50 years

T-score ≤−2.5 or fragility fracture (especially hip or vertebral compression fracture)

400

Bone indication for hyperparathyroidism-related parathyroidectomy

T-score ≤−2.5 or vertebral fracture

400

Highest-potency formulation among dermatologic ointments, solutions, and suspensions

Ointments

400

DIHS treatment

Discontinue causative drug, glucocorticoids

500

Most common cause of primary adrenal insufficiency (Addison disease)

Autoimmune adrenalitis

500

Prophylaxis for glucocorticoid-related osteoporosis

Bisphosphonate, denosumab

500

Drug class used before adrenalectomy for pheochromocytoma

α-Receptor blocker

500

Primary prognostic feature for melanoma

Depth of invasion (Breslow depth)

500

Hematologic conditions associated with Sweet syndrome

Myelodysplastic syndrome, AML